Polaris Palbociclib (IBRANCE®) in Hormone Receptor Positive Advanced Breast Cancer: A Prospective Multicenter Non-Interventional Study (NIS).

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/17 → 1/1/22

Funding

  • Pfizer